Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location Prognostic p-value RNA cancer category RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ABCB6 EST45597, MTABC3, umat ENSG00000115657 ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group) 2 219209768-219218990 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level HPA046723, HPA058011 Approved Validated Nucleoplasm
Golgi apparatus
Plasma membrane
Mitochondria
Cytosol Renal cancer:1.52e-7 (unfavourable), Liver cancer:9.45e-7 (unfavourable) Expressed in all Expressed in all testis: 32.5 AIG1 AIG-1, dJ95L4.1, FLJ10485 ENSG00000146416 Androgen-induced 1 6 143060496-143340304 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA060766 Approved Approved Golgi apparatus Head and neck cancer:3.25e-7 (unfavourable), Cervical cancer:3.26e-6 (unfavourable), Endometrial cancer:3.06e-4 (unfavourable) Expressed in all Expressed in all liver: 153.9 ANO9 PIG5, TMEM16J, TP53I5 ENSG00000185101 Anoctamin 9 11 417933-442011 Predicted membrane proteins, Transporters Evidence at protein level HPA039948, HPA040112 Approved Uncertain Golgi apparatus Urothelial cancer:8.81e-4 (favourable) Tissue enhanced Tissue enhanced duodenum: 32.4;small intestine: 31.6 skin: 21.6 APOH B2G1, BG ENSG00000091583 Apolipoprotein H (beta-2-glycoprotein I) 17 66212033-66256525 Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA001654, HPA003732, CAB022214 Supported Supported Golgi apparatus Liver cancer:2.39e-7 (favourable), Renal cancer:1.10e-6 (unfavourable) Tissue enriched Tissue enriched 278 liver: 9066.2 kidney: 32.6 ARFRP1 ARL18, ARP, Arp1 ENSG00000101246 ADP-ribosylation factor related protein 1 20 63698642-63708025 Predicted intracellular proteins Evidence at protein level HPA047028, HPA050634 Approved Supported Golgi apparatus Expressed in all Expressed in all spleen: 28.4 ARSI FLJ16069, SPG66 ENSG00000183876 Arylsulfatase family, member I 5 150296343-150339307 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA038386, HPA038398 Uncertain Approved Golgi apparatus Urothelial cancer:1.19e-4 (unfavourable), Lung cancer:9.11e-4 (unfavourable) Mixed Mixed skin: 5.7 ATAT1 C6orf134, Em:AB023049.7, FLJ13158, MEC17 ENSG00000137343 Alpha tubulin acetyltransferase 1 6 30626842-30646823 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA046816, HPA050999 Approved Approved Golgi apparatus
Cytosol Liver cancer:1.03e-5 (unfavourable), Renal cancer:7.78e-5 (unfavourable), Urothelial cancer:1.35e-4 (favourable) Expressed in all Mixed epididymis: 4.3 ATP7B WND ENSG00000123191 ATPase, Cu++ transporting, beta polypeptide 13 51930436-52012125 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level HPA009137, HPA013187 Supported Supported Golgi apparatus Endometrial cancer:5.01e-4 (unfavourable) Mixed Mixed testis: 14.0 ATP8B2 ATPID, KIAA1137 ENSG00000143515 ATPase, aminophospholipid transporter, class I, type 8B, member 2 1 154325553-154351307 Enzymes, Predicted membrane proteins Evidence at protein level HPA046680 Approved Approved Golgi apparatus
Vesicles
Cytosol Urothelial cancer:5.29e-5 (unfavourable), Pancreatic cancer:1.60e-4 (favourable) Expressed in all Mixed smooth muscle: 60.2 ATR FRP1, MEC1, SCKL, SCKL1 ENSG00000175054 ATR serine/threonine kinase 3 142449235-142578826 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA054320 Supported Nucleoplasm
Golgi apparatus Pancreatic cancer:1.23e-5 (unfavourable), Liver cancer:8.39e-5 (unfavourable) Expressed in all Mixed parathyroid gland: 15.2 B4GALNT3 B4GalNac-T3, FLJ16224, FLJ40362 ENSG00000139044 Beta-1,4-N-acetyl-galactosaminyl transferase 3 12 460364-563509 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA011404 Approved Supported Golgi apparatus
Vesicles Endometrial cancer:1.69e-10 (favourable) Mixed Tissue enhanced stomach: 69.0 colon: 22.0 C14orf80 ENSG00000185347 Chromosome 14 open reading frame 80 14 105489855-105499575 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA039049, HPA039050 Uncertain Approved Nucleoplasm
Golgi apparatus
Cytosol Liver cancer:3.54e-4 (unfavourable) Expressed in all Mixed appendix: 6.8 C8orf34 vest-1, VEST1 ENSG00000165084 Chromosome 8 open reading frame 34 8 68330722-68819022 Predicted intracellular proteins Evidence at protein level HPA044420, HPA053065 Uncertain Supported Nucleus
Nucleoli
Golgi apparatus Mixed Tissue enhanced fallopian tube: 15.1;parathyroid gland: 19.7 cerebral cortex: 6.1 C9orf85 MGC61599 ENSG00000155621 Chromosome 9 open reading frame 85 9 71911510-71986054 Predicted intracellular proteins Evidence at protein level HPA050767 Approved Nucleus
Nucleoli
Golgi apparatus Expressed in all Expressed in all thyroid gland: 13.9 CALML4 MGC4809, NY-BR-20 ENSG00000129007 Calmodulin-like 4 15 68190705-68206110 Predicted intracellular proteins Evidence at protein level HPA051109 Supported Approved Nucleoplasm
Golgi apparatus
Cytosol Mixed Tissue enhanced duodenum: 82.7;small intestine: 76.5 colon: 58.6 CAND1 DKFZp434M1414, KIAA0829, TIP120, TIP120A ENSG00000111530 Cullin-associated and neddylation-dissociated 1 12 67269281-67319951 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA055748, HPA062833, HPA069053 Approved Validated Nucleoplasm
Golgi apparatus
Cytosol Liver cancer:1.15e-4 (unfavourable) Expressed in all Expressed in all testis: 50.9 CCDC146 KIAA1505 ENSG00000135205 Coiled-coil domain containing 146 7 77122434-77329533 Predicted intracellular proteins Evidence at protein level HPA020082, HPA020105 Uncertain Approved Golgi apparatus
Vesicles Head and neck cancer:7.37e-4 (favourable) Expressed in all Tissue enhanced fallopian tube: 57.0;testis: 39.7 thyroid gland: 13.7 CCDC68 SE57-1 ENSG00000166510 Coiled-coil domain containing 68 18 54901509-54959508 Predicted intracellular proteins Evidence at protein level HPA040865, HPA048197 Supported Approved Golgi apparatus
Cytosol Cervical cancer:4.50e-4 (unfavourable), Renal cancer:5.28e-4 (favourable) Mixed Tissue enhanced placenta: 45.8 small intestine: 27.8 CCL15 HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3 ENSG00000275718 Chemokine (C-C motif) ligand 15 17 35996440-36002038 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA058608 Approved Golgi apparatus
Vesicles Urothelial cancer:3.02e-4 (favourable) Tissue enhanced Tissue enhanced duodenum: 22.1;rectum: 31.0;small intestine: 27.2 colon: 19.3 CCNI2 FLJ16793 ENSG00000205089 Cyclin I family, member 2 5 132747445-132754403 Predicted intracellular proteins Evidence at protein level HPA056288 Approved Approved Nucleoplasm
Golgi apparatus
Cytosol Colorectal cancer:8.21e-4 (favourable) Tissue enhanced Mixed duodenum: 3.9 CD44 CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1 ENSG00000026508 CD44 molecule (Indian blood group) 11 35138870-35232402 Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level CAB000112, CAB000316, HPA005785 Supported Validated Golgi apparatus
Plasma membrane Renal cancer:1.78e-8 (unfavourable) Expressed in all Expressed in all skin: 505.8 CD74 DHLAG ENSG00000019582 CD74 molecule, major histocompatibility complex, class II invariant chain 5 150401637-150412929 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level CAB002506, HPA010592 Supported Supported Golgi apparatus Endometrial cancer:6.53e-6 (favourable), Breast cancer:1.06e-4 (favourable) Expressed in all Expressed in all spleen: 6665.5 CDC6 CDC18L ENSG00000094804 Cell division cycle 6 17 40287633-40304657 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA050114, HPA054703 Approved Supported Nucleoplasm
Golgi apparatus
Cytosol Liver cancer:5.96e-8 (unfavourable), Pancreatic cancer:2.90e-4 (unfavourable) Expressed in all Mixed appendix: 15.8 COG8 DOR1, FLJ22315 ENSG00000213380 Component of oligomeric golgi complex 8 16 69320140-69339667 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA041406, HPA049429 Approved Supported Golgi apparatus Renal cancer:2.47e-7 (favourable), Pancreatic cancer:3.12e-5 (favourable) Expressed in all Expressed in all testis: 39.6 COPG1 COPG ENSG00000181789 Coatomer protein complex, subunit gamma 1 3 129249606-129277773 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA037866, HPA037867, HPA045712 Supported Supported Nucleoplasm
Golgi apparatus
Cytosol Liver cancer:1.22e-6 (unfavourable) Expressed in all Expressed in all epididymis: 188.8 CXCL8 3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1 ENSG00000169429 Chemokine (C-X-C motif) ligand 8 4 73740506-73743716 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level HPA057179 Supported Approved Golgi apparatus Renal cancer:3.13e-6 (unfavourable), Cervical cancer:1.18e-5 (unfavourable), Liver cancer:1.19e-5 (unfavourable) Expressed in all Tissue enriched 7 bone marrow: 2079.8 appendix: 297.8 CYP2D6 CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D ENSG00000100197 Cytochrome P450, family 2, subfamily D, polypeptide 6 22 42126499-42130906 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA045223 Supported Uncertain Golgi apparatus Tissue enriched Tissue enhanced liver: 11.4;small intestine: 13.2 duodenum: 3.9 DIEXF C1orf107, DEF, MGC29875, UTP25 ENSG00000117597 Digestive organ expansion factor homolog (zebrafish) 1 209828007-209857565 Predicted intracellular proteins Evidence at protein level HPA026640, HPA061682 Approved Approved Nucleoplasm
Golgi apparatus Expressed in all Mixed ovary: 8.8 DTX3 FLJ34766, RNF154 ENSG00000178498 Deltex 3, E3 ubiquitin ligase 12 57604622-57609804 Predicted intracellular proteins Evidence at protein level HPA059654 Approved Approved Nucleus
Nucleoli
Golgi apparatus Pancreatic cancer:1.44e-4 (favourable), Lung cancer:9.87e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 103.1 DUSP10 MKP-5, MKP5 ENSG00000143507 Dual specificity phosphatase 10 1 221701424-221742176 Enzymes, Predicted intracellular proteins Evidence at protein level HPA016758 Approved Supported Nucleoplasm
Golgi apparatus
Cytosol Renal cancer:3.69e-4 (unfavourable), Liver cancer:5.42e-4 (favourable) Expressed in all Mixed liver: 16.8 EFHD1 FLJ13612 ENSG00000115468 EF-hand domain family, member D1 2 232606057-232682781 Predicted intracellular proteins Evidence at protein level HPA049331, HPA056959 Supported Supported Nucleoli fibrillar center
Golgi apparatus Renal cancer:2.93e-7 (favourable) Expressed in all Tissue enhanced breast: 225.2 kidney: 176.1 EHF ESE3, ESEJ ENSG00000135373 Ets homologous factor 11 34621093-34661057 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level HPA050923, HPA060734 Approved Supported Nucleoplasm
Golgi apparatus Colorectal cancer:5.81e-4 (favourable), Pancreatic cancer:6.94e-4 (unfavourable) Mixed Mixed esophagus: 229.2 ENPP6 MGC33971 ENSG00000164303 Ectonucleotide pyrophosphatase/phosphodiesterase 6 4 184088706-184221230 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA042740 Approved Uncertain Golgi apparatus Tissue enriched Tissue enhanced kidney: 30.5;ovary: 15.0 cerebral cortex: 8.7 ESD ENSG00000139684 Esterase D 13 46771256-46797232 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA039700 Approved Approved Golgi apparatus
Cytosol Head and neck cancer:2.16e-4 (unfavourable), Cervical cancer:5.01e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 244.5 FAM114A1 Noxp20 ENSG00000197712 Family with sequence similarity 114, member A1 4 38867677-38945739 Predicted intracellular proteins Evidence at protein level HPA067948, HPA069104, HPA069701 Uncertain Validated Nucleus
Golgi apparatus
Cytosol Renal cancer:3.63e-6 (unfavourable) Expressed in all Expressed in all smooth muscle: 87.5 FKBP9 FKBP60, FKBP63 ENSG00000122642 FK506 binding protein 9, 63 kDa 7 32957404-33006931 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA012595, HPA055256 Approved Approved Golgi apparatus
Vesicles
Mitochondria Urothelial cancer:7.02e-6 (unfavourable), Head and neck cancer:2.02e-4 (unfavourable), Cervical cancer:4.22e-4 (unfavourable), Glioma:8.06e-4 (unfavourable), Liver cancer:8.69e-4 (unfavourable) Expressed in all Expressed in all placenta: 109.6 FUT6 FCT3A, FLJ40754, FT1A, FucT-VI ENSG00000156413 Fucosyltransferase 6 (alpha (1,3) fucosyltransferase) 19 5830610-5839731 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA043707, HPA046966 Approved Supported Golgi apparatus Renal cancer:3.17e-8 (favourable), Head and neck cancer:2.12e-4 (favourable) Mixed Tissue enhanced esophagus: 50.0;kidney: 34.3 small intestine: 31.2 GALNT14 FLJ12691, GalNac-T10, GalNac-T14 ENSG00000158089 Polypeptide N-acetylgalactosaminyltransferase 14 2 30910467-31155202 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA030138 Approved Nucleus
Golgi apparatus Tissue enriched Tissue enhanced kidney: 40.0 parathyroid gland: 12.5 GCNT2 bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3 ENSG00000111846 Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) 6 10492223-10629368 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA026776 Approved Supported Golgi apparatus Mixed Tissue enhanced prostate: 49.8 breast: 14.2 GCNT4 C2GNT3 ENSG00000176928 Glucosaminyl (N-acetyl) transferase 4, core 2 5 75025346-75030899 Enzymes, Predicted intracellular proteins Evidence at protein level HPA037431 Approved Supported Nucleoplasm
Golgi apparatus Renal cancer:1.93e-7 (favourable) Mixed Tissue enhanced duodenum: 22.0 parathyroid gland: 20.7 GDPD5 GDE2, PP1665 ENSG00000158555 Glycerophosphodiester phosphodiesterase domain containing 5 11 75434640-75525903 Predicted membrane proteins Evidence at protein level HPA065257, HPA066762, HPA069281 Uncertain Approved Golgi apparatus Renal cancer:6.59e-9 (unfavourable), Endometrial cancer:1.29e-4 (unfavourable) Expressed in all Tissue enhanced spleen: 68.0 testis: 31.2 GOLGA1 golgin-97, MGC33154 ENSG00000136935 Golgin A1 9 124878357-124948492 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB013065, HPA044329, HPA050555 Supported Validated Golgi apparatus Endometrial cancer:2.21e-4 (favourable) Expressed in all Expressed in all testis: 28.7 GOLGA8A GM88, GOLGIN-67 ENSG00000175265 Golgin A8 family, member A 15 34379068-34437466 Predicted intracellular proteins Evidence at transcript level HPA051808 Approved Golgi apparatus
Cytosol Renal cancer:2.16e-6 (unfavourable), Urothelial cancer:5.68e-6 (favourable), Lung cancer:7.58e-4 (favourable) Expressed in all Mixed skin: 41.1 GOLGA8B ENSG00000215252 Golgin A8 family, member B 15 34525207-34588503 Predicted intracellular proteins Evidence at transcript level HPA051808 Approved Golgi apparatus
Cytosol Renal cancer:9.38e-6 (unfavourable), Urothelial cancer:5.79e-4 (favourable) Expressed in all Tissue enhanced thyroid gland: 47.6 testis: 23.5 GOPC CAL, dJ94G16.2, FIG, GOPC1, PIST ENSG00000047932 Golgi-associated PDZ and coiled-coil motif containing 6 117560269-117602542 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level HPA019477, HPA024018 Approved Validated Golgi apparatus
Cytosol Expressed in all Expressed in all parathyroid gland: 47.0 HELLS LSH, Nbla10143, PASG, SMARCA6 ENSG00000119969 Helicase, lymphoid-specific 10 94501434-94613905 Predicted intracellular proteins Evidence at protein level CAB004491, HPA063242 Supported Approved Nucleus
Golgi apparatus
Vesicles Cervical cancer:1.36e-4 (favourable) Expressed in all Tissue enhanced testis: 23.9 lymph node: 15.1 HEPN1 ENSG00000221932 Hepatocellular carcinoma, down-regulated 1 11 124919244-124920677 Predicted intracellular proteins Evidence at transcript level HPA043768, HPA063054 Uncertain Approved Golgi apparatus Not detected Tissue enriched 6 cerebral cortex: 79.7 adipose tissue: 12.9 HMP19 ENSG00000170091 HMP19 protein 5 174045604-174243501 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA056191 Supported Approved Golgi apparatus Tissue enriched Tissue enriched 7 cerebral cortex: 289.3 adrenal gland: 42.2 IGFBP1 AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12 ENSG00000146678 Insulin-like growth factor binding protein 1 7 45888357-45893668 Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level CAB004445, HPA046972, HPA050640 Supported Approved Golgi apparatus Renal cancer:6.90e-11 (unfavourable), Lung cancer:1.03e-4 (unfavourable), Stomach cancer:6.64e-4 (unfavourable) Tissue enriched Group enriched 53 endometrium: 120.4;liver: 562.2;placenta: 264.8 fallopian tube: 5.9 ITGA4 CD49D ENSG00000115232 Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) 2 181457202-181536187 Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA064041 Approved Golgi apparatus
Vesicles Renal cancer:3.08e-5 (unfavourable), Head and neck cancer:8.29e-4 (favourable) Mixed Tissue enhanced spleen: 68.6 appendix: 51.2 ITIH2 H2P ENSG00000151655 Inter-alpha-trypsin inhibitor heavy chain 2 10 7703269-7749520 Plasma proteins, Predicted secreted proteins Evidence at protein level HPA059150 Supported Approved Golgi apparatus Liver cancer:1.48e-4 (favourable) Tissue enriched Tissue enriched 207 liver: 1092.2 cerebral cortex: 5.2 LRRC8C AD158 ENSG00000171488 Leucine rich repeat containing 8 family, member C 1 89633072-89769903 Predicted membrane proteins, Transporters Evidence at protein level HPA029347 Uncertain Approved Golgi apparatus Renal cancer:3.75e-4 (unfavourable) Expressed in all Mixed smooth muscle: 22.4 MAGEA9 CT1.9, MAGE9, MGC8421 ENSG00000123584 Melanoma antigen family A9 X 149781930-149787737 Predicted intracellular proteins Evidence at protein level HPA045401 Approved Golgi apparatus Not detected Not detected testis: 0.6 MAGEA9B ENSG00000267978 Melanoma antigen family A9B X 149581653-149587453 Predicted intracellular proteins Evidence at protein level HPA045401 Approved Golgi apparatus Tissue enhanced Tissue enriched 36 testis: 17.3 placenta: 0.4 MAN1A1 ENSG00000111885 Mannosidase, alpha, class 1A, member 1 6 119177209-119349761 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level CAB037058, HPA053198, HPA063561 Uncertain Supported Golgi apparatus
Cytosol Expressed in all Expressed in all placenta: 111.4 MANEA FLJ12838, mandaselin ENSG00000172469 Mannosidase, endo-alpha 6 95577543-95609457 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA011046, HPA011069 Supported Supported Golgi apparatus Colorectal cancer:3.04e-4 (favourable) Expressed in all Mixed thyroid gland: 19.4 MGAT4A GnT-4a, GnT-Iva ENSG00000071073 Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A 2 98619106-98731126 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA007608 Supported Approved Golgi apparatus Endometrial cancer:6.48e-8 (unfavourable), Breast cancer:4.30e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 82.4 NAA25 C12orf30, FLJ13089 ENSG00000111300 N(alpha)-acetyltransferase 25, NatB auxiliary subunit 12 112026689-112109022 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA039322 Approved Supported Golgi apparatus
Cytosol Renal cancer:1.32e-8 (unfavourable), Liver cancer:5.53e-5 (unfavourable), Endometrial cancer:2.26e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 9.4 NTAN1 ENSG00000157045 N-terminal asparagine amidase 16 15037853-15056079 Predicted intracellular proteins Evidence at protein level HPA051418 Approved Nucleoplasm
Golgi apparatus Glioma:8.85e-4 (unfavourable), Stomach cancer:9.07e-4 (unfavourable) Expressed in all Expressed in all epididymis: 19.9 PCDH10 KIAA1400, OL-PCDH ENSG00000138650 Protocadherin 10 4 133149315-133208606 Predicted membrane proteins Evidence at protein level HPA011220, HPA073462 Approved Approved Nucleus
Golgi apparatus
Vesicles Tissue enhanced Group enriched 5 cerebral cortex: 62.2;placenta: 36.4;prostate: 17.0;seminal vesicle: 24.4 adrenal gland: 6.9 PCDH18 KIAA1562, PCDH68L ENSG00000189184 Protocadherin 18 4 137518918-137532494 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA017976 Approved Approved Golgi apparatus
Cytosol Renal cancer:3.21e-4 (unfavourable), Urothelial cancer:4.71e-4 (unfavourable) Mixed Mixed placenta: 64.0 PCOLCE PCPE, PCPE1 ENSG00000106333 Procollagen C-endopeptidase enhancer 7 100602177-100608175 Plasma proteins, Predicted secreted proteins Evidence at protein level CAB017623, HPA042927 Approved Approved Golgi apparatus
Vesicles Renal cancer:1.68e-5 (unfavourable), Melanoma:9.76e-4 (unfavourable) Expressed in all Tissue enhanced cervix, uterine: 215.7 gallbladder: 146.7 PLAGL1 LOT1, ZAC ENSG00000118495 Pleiomorphic adenoma gene-like 1 6 143940300-144064599 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA055706 Supported Nuclear bodies
Golgi apparatus
Vesicles Renal cancer:4.94e-6 (unfavourable), Stomach cancer:6.61e-4 (unfavourable) Mixed Expressed in all placenta: 362.2 PLCXD3 ENSG00000182836 Phosphatidylinositol-specific phospholipase C, X domain containing 3 5 41306954-41510628 Predicted intracellular proteins Evidence at protein level HPA046849 Uncertain Approved Golgi apparatus Mixed Tissue enhanced adrenal gland: 16.8;heart muscle: 21.1;ovary: 28.3 cerebral cortex: 8.3 PNRC2 ENSG00000189266 Proline-rich nuclear receptor coactivator 2 1 23959109-23963462 Predicted intracellular proteins Evidence at protein level HPA027820, HPA045837 Uncertain Supported Nucleoplasm
Golgi apparatus Liver cancer:7.97e-5 (unfavourable), Melanoma:1.41e-4 (unfavourable), Urothelial cancer:4.05e-4 (favourable), Breast cancer:6.02e-4 (favourable) Expressed in all Expressed in all thyroid gland: 202.7 PPP1R15B FLJ14744 ENSG00000158615 Protein phosphatase 1, regulatory subunit 15B 1 204403387-204411791 Predicted intracellular proteins Evidence at protein level HPA061088 Approved Golgi apparatus Renal cancer:8.74e-5 (unfavourable) Expressed in all Expressed in all bone marrow: 81.7 PSEN1 AD3, FAD, PS1, S182 ENSG00000080815 Presenilin 1 14 73136418-73223691 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level CAB006844, HPA030760, HPA067496 Approved Approved Nucleus
Golgi apparatus
Cell Junctions Renal cancer:1.52e-8 (favourable), Liver cancer:1.99e-5 (unfavourable) Expressed in all Expressed in all cerebral cortex: 66.1 PSMG1 c21-LRP, DSCR2, LRPC21, PAC1 ENSG00000183527 Proteasome (prosome, macropain) assembly chaperone 1 21 39174769-39183851 Predicted intracellular proteins Evidence at protein level HPA057193, HPA070225 Approved Approved Nucleoplasm
Golgi apparatus
Cytosol Renal cancer:3.58e-5 (unfavourable) Expressed in all Expressed in all testis: 68.5 QPCTL FLJ20084 ENSG00000011478 Glutaminyl-peptide cyclotransferase-like 19 45692483-45703989 Enzymes, Predicted intracellular proteins Evidence at protein level HPA040797 Approved Supported Golgi apparatus Renal cancer:2.15e-8 (unfavourable) Expressed in all Mixed thyroid gland: 8.6 RBFOX1 A2BP1, FOX-1, HRNBP1 ENSG00000078328 RNA binding protein, fox-1 homolog (C. elegans) 1 16 6019094-7713338 Predicted intracellular proteins Evidence at protein level HPA040809 Supported Approved Nucleus
Golgi apparatus
Cytosol Tissue enhanced Tissue enhanced cerebral cortex: 110.9;skeletal muscle: 32.9 heart muscle: 14.8 RER1 ENSG00000157916 Retention in endoplasmic reticulum sorting receptor 1 1 2391775-2405444 Predicted membrane proteins, Transporters Evidence at protein level CAB037240, HPA051400 Supported Validated Golgi apparatus Renal cancer:8.23e-8 (unfavourable) Expressed in all Expressed in all testis: 183.8 RINT1 FLJ11785, RINT-1 ENSG00000135249 RAD50 interactor 1 7 105532085-105567677 Predicted intracellular proteins Evidence at protein level HPA019875, HPA031646 Approved Approved Golgi apparatus Thyroid cancer:2.39e-5 (unfavourable) Expressed in all Expressed in all testis: 18.9 RP1-179P9.3 ENSG00000282218 6 117318211-117573571 Predicted intracellular proteins Evidence at transcript level HPA019477 Uncertain Approved Golgi apparatus
Cytosol Not detected epididymis,lung: 0.8 SEC11A SEC11L1, sid2895, SPC18, SPCS4A ENSG00000140612 SEC11 homolog A, signal peptidase complex subunit 15 84669538-84716716 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA047533 Approved Nuclear membrane
Golgi apparatus Endometrial cancer:1.94e-5 (favourable), Head and neck cancer:5.99e-5 (unfavourable), Thyroid cancer:2.95e-4 (favourable) Expressed in all Expressed in all thyroid gland: 211.4 SEC11C SEC11L3, SPC21, SPCS4C ENSG00000166562 SEC11 homolog C, signal peptidase complex subunit 18 59139477-59158836 Enzymes, Predicted membrane proteins Evidence at protein level HPA026816, HPA047533 Approved Approved Nuclear membrane
Golgi apparatus Expressed in all Expressed in all prostate: 275.4 SIPA1L2 KIAA1389 ENSG00000116991 Signal-induced proliferation-associated 1 like 2 1 232397965-232561558 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA024181, HPA027224 Approved Approved Nuclear membrane
Nuclear bodies
Golgi apparatus Renal cancer:8.15e-4 (unfavourable) Expressed in all Mixed placenta: 28.9 SLA2 C20orf156, FLJ21992, SLAP-2 ENSG00000101082 Src-like-adaptor 2 20 36612318-36646216 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA053746, HPA058217 Approved Nucleoplasm
Golgi apparatus
Vesicles Renal cancer:6.77e-8 (unfavourable), Cervical cancer:7.36e-4 (favourable) Mixed Mixed lymph node: 11.9 SLC35C2 bA394O2.1, C20orf5, CGI-15, OVCOV1 ENSG00000080189 Solute carrier family 35 (GDP-fucose transporter), member C2 20 46345980-46364458 Predicted membrane proteins, Transporters Evidence at protein level HPA027011 Approved Supported Nucleoplasm
Golgi apparatus Liver cancer:1.08e-4 (unfavourable), Renal cancer:8.68e-4 (unfavourable) Expressed in all Expressed in all fallopian tube: 36.6 SLC35F3 FLJ37712 ENSG00000183780 Solute carrier family 35, member F3 1 233904933-234324516 Predicted membrane proteins, Transporters Evidence at protein level HPA051327, HPA061582 Uncertain Approved Nucleoli
Golgi apparatus Mixed Tissue enhanced cerebral cortex: 10.2 breast: 3.0 SPRY4 ENSG00000187678 Sprouty RTK signaling antagonist 4 5 142310427-142326455 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB008086, HPA055471 Approved Supported Golgi apparatus
Cytosol Renal cancer:2.20e-4 (unfavourable), Cervical cancer:7.12e-4 (unfavourable) Expressed in all Mixed adipose tissue: 26.7 ST8SIA3 SIAT8C ENSG00000177511 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 18 57350813-57371731 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA063398, HPA066783 Supported Supported Golgi apparatus Group enriched Tissue enriched 7 cerebral cortex: 31.9 adrenal gland: 4.8 STX12 STX13, STX14 ENSG00000117758 Syntaxin 12 1 27773183-27824452 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA041038, HPA055300 Approved Supported Nucleoplasm
Golgi apparatus
Vesicles Expressed in all Expressed in all thyroid gland: 155.4 SYDE2 FLJ13815 ENSG00000097096 Synapse defective 1, Rho GTPase, homolog 2 (C. elegans) 1 85156873-85201046 Predicted intracellular proteins Evidence at protein level HPA027138, HPA058378 Uncertain Approved Nucleoli
Golgi apparatus Mixed Mixed parathyroid gland: 6.9 SYNGR4 ENSG00000105467 Synaptogyrin 4 19 48364395-48376376 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level HPA030075, HPA059286 Approved Approved Golgi apparatus Mixed Tissue enriched 11 testis: 46.8 parathyroid gland: 4.4 TBC1D14 KIAA1322 ENSG00000132405 TBC1 domain family, member 14 4 6909242-7033118 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA036930, HPA067398 Approved Supported Nucleoplasm
Golgi apparatus
Vesicles Renal cancer:5.28e-10 (favourable) Expressed in all Expressed in all cerebral cortex: 67.7 VTI1B VTI2 ENSG00000100568 Vesicle transport through interaction with t-SNAREs 1B 14 67647075-67674831 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA044121, HPA048150, HPA060118 Approved Validated Golgi apparatus
Vesicles Renal cancer:3.53e-12 (favourable) Expressed in all Expressed in all epididymis: 62.3 YIPF2 FinGER2, MGC3262 ENSG00000130733 Yip1 domain family, member 2 19 10922185-10928681 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA019902 Approved Approved Golgi apparatus
Mitochondria Expressed in all Expressed in all testis: 73.3 ZCCHC5 FLJ38865, Mar3, Mart3, ZHC5 ENSG00000179300 Zinc finger, CCHC domain containing 5 X 78656069-78659328 Predicted intracellular proteins Evidence at transcript level HPA051991, HPA053174, HPA075136 Uncertain Approved Nucleoplasm
Golgi apparatus
Plasma membrane Not detected Not detected endometrium,smooth muscle: 0.7 ZNF25 FLJ31890, KOX19, Zfp9 ENSG00000175395 Zinc finger protein 25 10 37949572-37976633 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA030190 Uncertain Approved Nucleoplasm
Golgi apparatus Expressed in all Mixed cerebral cortex: 27.0